Our agency has communicated some of the most promising CV trial data of the past decade, and through the years, we have developed deep relationships with leading cardiologists and advocacy organizations, including the American Heart Association, the American Society of Hypertension, the Sister to Sister Foundation, the National Lipid Association, and the National Stroke Association.
Diseases of the skin are often the first thing patients seek to treat, but the last to work to prevent. We know how to communicate about both treatment and prevention in this space. Our collective staff experience spans the universe of dermatology products from topicals to injections and infusions. Our expertise includes actinic keratosis, acne, dermatitis, eczema, psoriasis, and warts.
We have launched new diabetes treatments, partnered with the community to drive disease understanding, and created new educational vehicles for people with diabetes through gaming and social media. In 2010, we created the first diabetes education game on Facebook®, called HealthSeeker, which has generated thousands of fans and active users.
Chamberlain’s efforts in infectious disease directly target superbug resistance, which is a continuing challenge to the healthcare industry. Recognizing our clients’ need to simultaneously differentiate and educate, we provide innovative communications strategies to target all stakeholders.
The Chamberlain team has long-standing experience delving into neuroscience and explaining it in the socially charged context of patients and families living with diseases of the mind. We understand the political and cultural environment that complicates communications in this space, and have spent years shaping the standards by which the media addresses new developments and discoveries about the brain.
From early clinical development to access and reimbursement, we have strong insights into the needs of people living with cancer, as well as an understanding of the scientific data that drive relevant conversations in the healthcare community. Our oncology expertise is rooted in breast cancer, clinical trial awareness, hematology, kidney cancer, lung cancer, and supportive care.
Chamberlain knows how difficult it can be to navigate the pain community. We believe that validating the patient experience and recognizing the challenges patients and their doctors face is essential to successful PR programming in this category. Our efforts have reached professional and consumer audiences through regulatory milestones, large-scale celebrity campaigns, data dissemination at U.S. and global medical meetings and relationships with advocacy groups.